O
OCUL
Ocular Therapeut
9.01
-0.14-1.53%After Hours: 9.05 +0.04 +0.44%17:54 05/29 EDT
OPEN/PREV CLOSE9.16/9.15
TODAY RANGE8.96-9.27
VOL2.41M
MARKET CAP1.97B
52 WEEK RANGE6.23-16.44
AVG VOL (3M)3.52M
% TURNOVER1.10%
TURNOVER--
P/E (TTM)-6.1890
% RANGE3.44%
EPS(TTM)-1.4558
P/E(FORWARD)-5.5617
P/B3.391
BVPS2.657
DIVIDEND--
P/S37.45
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.93B
SHARES OUTSTANDING218.96M
NEXT EARNINGS08/03-08/07
FREE FLOAT214.31M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·05/11 12:02
Dole Posts Downbeat Q1 Earnings, Joins Ocular Therapeutix And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Seeking Alpha·05/07 12:00
Ocular: SOL-1 Success Is Real, But Adoption Risks Keep Me At Hold
Dow Jones·05/07 09:52
Ocular Therapeutix Price Target Maintained With a $18.00/Share by Needham
Dow Jones·05/06 15:59
Ocular Therapeutix Price Target Maintained With a $30.00/Share by RBC Capital
TipRanks·05/06 12:19
Ocular Therapeutix (OCUL) Gets a Buy from Chardan Capital
TipRanks·05/06 10:38
Ocular Therapeutix (OCUL) Gets a Buy from H.C. Wainwright
Seeking Alpha·05/05 18:42
Ocular Therapeutix outlines SOL-R top line data in Q1 2027 while advancing AXPAXLI NDA plan
Same Industry
Name/Symbol
Change%
Price